BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26917100)

  • 1. Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.
    Cheriyan J; Balsara RD; Hansen KB; Castellino FJ
    Neurosci Lett; 2016 Mar; 617():240-6. PubMed ID: 26917100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
    Hansen KB; Ogden KK; Yuan H; Traynelis SF
    Neuron; 2014 Mar; 81(5):1084-1096. PubMed ID: 24607230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
    Chen X; Keramidas A; Harvey RJ; Lynch JW
    Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities for Precision Treatment of
    Han W; Yuan H; Allen JP; Kim S; Shaulsky GH; Perszyk RE; Traynelis SF; Myers SJ
    J Pharmacol Exp Ther; 2022 Apr; 381(1):54-66. PubMed ID: 35110392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic conantokin peptides potently inhibit N-methyl-D-aspartate receptor-mediated currents of retinal ganglion cells.
    Huang L; Balsara RD; Castellino FJ
    J Neurosci Res; 2014 Dec; 92(12):1767-74. PubMed ID: 25043917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
    Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
    J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mg2+ block properties of triheteromeric GluN1-GluN2B-GluN2D NMDA receptors on neonatal rat substantia nigra pars compacta dopaminergic neurones.
    Huang Z; Gibb AJ
    J Physiol; 2014 May; 592(10):2059-78. PubMed ID: 24614743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner.
    Edman S; McKay S; Macdonald LJ; Samadi M; Livesey MR; Hardingham GE; Wyllie DJ
    Neuropharmacology; 2012 Sep; 63(3):441-9. PubMed ID: 22579927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of Triheteromeric
    Yi F; Zachariassen LG; Dorsett KN; Hansen KB
    Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
    Izumi Y; Zorumski CF
    J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.
    Yi F; Bhattacharya S; Thompson CM; Traynelis SF; Hansen KB
    J Physiol; 2019 Nov; 597(22):5495-5514. PubMed ID: 31541561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triheteromeric NMDA receptors: from structure to synaptic physiology.
    Stroebel D; Casado M; Paoletti P
    Curr Opin Physiol; 2018 Apr; 2():1-12. PubMed ID: 29682629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric Interactions between NMDA Receptor Subunits Shape the Developmental Shift in Channel Properties.
    Sun W; Hansen KB; Jahr CE
    Neuron; 2017 Apr; 94(1):58-64.e3. PubMed ID: 28384476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
    Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
    J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spermidine and Ca(2+), but not Na(+), can permeate NMDA receptors consisting of GluN1 and GluN2A or GluN2B in the presence of Mg(2+).
    Hirose T; Saiki R; Yoshizawa Y; Imamura M; Higashi K; Ishii I; Toida T; Williams K; Kashiwagi K; Igarashi K
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1190-5. PubMed ID: 26086092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation.
    Lü W; Du J; Goehring A; Gouaux E
    Science; 2017 Mar; 355(6331):. PubMed ID: 28232581
    [No Abstract]   [Full Text] [Related]  

  • 17. Probing NMDA receptor GluN2A and GluN2B subunit expression and distribution in cortical neurons.
    Balsara RD; Ferreira AN; Donahue DL; Castellino FJ; Sheets PL
    Neuropharmacology; 2014 Apr; 79():542-9. PubMed ID: 24440368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Cell-Surface Expression of Triheteromeric NMDA Receptors.
    Yi F; Traynelis SF; Hansen KB
    Methods Mol Biol; 2017; 1677():145-162. PubMed ID: 28986871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triheteromeric GluN1/GluN2A/GluN2C NMDARs with Unique Single-Channel Properties Are the Dominant Receptor Population in Cerebellar Granule Cells.
    Bhattacharya S; Khatri A; Swanger SA; DiRaddo JO; Yi F; Hansen KB; Yuan H; Traynelis SF
    Neuron; 2018 Jul; 99(2):315-328.e5. PubMed ID: 30056832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ifenprodil on GluN1/GluN2B N-methyl-D-aspartate receptor gating.
    Bhatt JM; Prakash A; Suryavanshi PS; Dravid SM
    Mol Pharmacol; 2013 Jan; 83(1):9-21. PubMed ID: 23007555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.